4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001614740-26-000002
CHIEF EXECUTIVE OFFICER sold 7,098 shares at $93.33 ($662,422)
- CHIEF EXECUTIVE OFFICER acquired 12,797 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2026-01-21 | Option exercise | +12,797 | 170,831 | D: show line 1 in the form | ||
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2026-01-22 | Sale | −7,098 | $93.33 | $662,422 | 163,733 | D: show line 2 in the form |
| Open-market sales · 7,098 sh · avg $93.33 · $662,422 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2026-01-21 | Option exercise · Restricted Stock Units | −12,797 | 25,593 | D: show line 3 in the form |
Loading xslF345X05/form4-01232026_050101.xml…